Case Studies

Overcoming Inventory Stagnation Through Dynamic Demand-Based Ordering Decisions

Posted by | Fuld & Company

A global cosmetics brand facing inventory stagnation wanted to introduce better analytics to inform their decision-making regarding stock.


To increase demand and create an optimal price model, with the aim of maximizing sales and developing a dynamic decision-making system that could optimize the store inventory.


  • Collected weekly price and sales data, including total category sales and average product prices from 3P data sources. Also considered holidays and events as exogenous variables.
  • Leveraged machine learning algorithms (such as OLS and SARIMAX) to predict brand demand and optimal pricing to maximize sales.
  • Leveraged model equations to set up a Markov Decision Process to evaluate end-of-week inventory for each store and defined a more dynamic demand-based re-ordering algorithm that considered the company’s order lead time.


  • After 11 weeks of change management efforts with the brand’s leadership, the company trial tested the model at five stores in New York, Florida, California, Washington, and Illinois.
  • The stores cleared their stagnating inventory within five to nine weeks, and the four-week average value of inventory at these stores dropped by US$1.8 million cumulatively. The stores did not report any stockouts during the test period.

Algorithms Used: Econometric models such as OLS and SARIMAX and the Markov Decision Process



Tags: , ,

Related Resources

Read More

Sustainable innovation in the polymer industry

Delivering sustainable innovation How we helped a leading industrial polymer manufacturer cut 1.5 years off its R&D timeline… and win […]

Read More

Leveraging Machine Learning in Customer Sentiment Analysis

In a highly competitive market, staying ahead of customer expectations is critical for any manufacturer. A leading US plumbing fixture […]

Read More

Healthcare and Pharma Competitive Intelligence Dashboard

A US-based healthcare company wanted to explore its options for a clinical drug development strategy that would minimize its time […]

Subscribe to our mailing list for our latest updates: